A Tobler
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 15
- Chronic Myeloid Leukemia Treatments 8
- Genetics 18
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 6
- Co-authors
- Martin F. FeyH. Phillip KoefflerJudith C. GassonM.F. FeyJ SchwallerH StuderAnthony W. NormanTobias Grob
- Journals
- Annals of Oncology (8 papers)Blood (8 papers)Leukemia (5 papers)Journal of Clinical Investigation (5 papers)Annals of Hematology (5 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
A Tobler
70 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 119
- Hematology 550
- Genetics 394
- Oncology 806
- Pathology and Forensic Medicine 370
- Immunology 420
Countries citing papers authored by A Tobler
This map shows the geographic impact of A Tobler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Tobler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Tobler more than expected).
Fields of papers citing papers by A Tobler
This network shows the impact of papers produced by A Tobler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Tobler. The network helps show where A Tobler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside A Tobler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 11 | |
| 2 | 2008 | 35 | |
| 3 | 2006 | 6 | |
| 4 | 2004 | 6 | |
| 5 | 2002 | 37 | |
| 6 | 2001 | 293 | |
| 7 | 2000 | 85 | |
| 8 | 1999 | 13 | |
| 9 | 1998 | 24 | |
| 10 | 1997 | 28 | |
| 11 | 1997 | 14 | |
| 12 | 1996 | 8 | |
| 13 | 1995 | 24 | |
| 14 | 1994 | 65 | |
| 15 | 1993 | 2 | |
| 16 | 1993 | 3 | |
| 17 | 1992 | 4 | |
| 18 | 1991 | 18 | |
| 19 | 1991 | 12 | |
| 20 | 1990 | 1 |
About A Tobler
A Tobler is a scholar working on Hematology, Genetics, Immunology, Pathology and Forensic Medicine and Oncology, having authored 70 papers that have together received 2.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (10 papers), Cancer-related Molecular Pathways (10 papers), Lymphoma Diagnosis and Treatment (10 papers), Chronic Myeloid Leukemia Treatments (8 papers), Immune Response and Inflammation (7 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Hematology (550 citations), Genetics (394 citations), Oncology (806 citations), Pathology and Forensic Medicine (370 citations) and Immunology (420 citations). A Tobler has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Martin F. Fey, H. Phillip Koeffler, Judith C. Gasson, M.F. Fey, J Schwaller, H Studer, Anthony W. Norman, Tobias Grob, Pius Loetscher and Barbara Hügli. Their work appears in journals such as Annals of Oncology, Blood, Leukemia, Journal of Clinical Investigation and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.